Literature DB >> 36128498

Impact of Medication Reconciliation by a Dialysis Pharmacist.

Summer A Dyer1, Victoria Nguyen2, Sally Rafie1, Linda Awdishu2.   

Abstract

Integrating a pharmacist into a hemodialysis unit significantly reduced medication discrepancies and medication-related problems over time.Medication reconciliation for the Centers for Medicare and Medicaid Services End-Stage Renal Disease Quality Incentive Program can be optimally performed by a dialysis pharmacist.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  dialysis; medication discrepancy; medication error; medication reconciliation; medication related problems; medication safety; pharmacist; pharmacy

Mesh：

Year:  2022        PMID： 36128498      PMCID： PMC9438412          DOI： 10.34067/KID.0007182021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


  9 in total

1.  Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach.

Authors:  Amy Barton Pai; Katie E Cardone; Harold J Manley; Wendy L St Peter; Rachel Shaffer; Michael Somers; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

2.  Severity-indexed, incident report-based medication error-reporting program.

Authors:  S C Hartwig; S D Denger; P J Schneider
Journal:  Am J Hosp Pharm       Date:  1991-12

3.  Best possible medication history for hemodialysis patients obtained by a pharmacy technician.

Authors:  Marianna Leung; Joanne Jung; Wynnie Lau; Mercedeh Kiaii; Beverly Jung
Journal:  Can J Hosp Pharm       Date:  2009-09

4.  Multidisciplinary views toward pharmacist-delivered medication therapy management services in dialysis facilities.

Authors:  Wendy M Parker; Soo Min Jang; Julia D Muzzy; Katie E Cardone
Journal:  J Am Pharm Assoc (2003)       Date:  2015 Jul-Aug

5.  A formal medication reconciliation programme in a haemodialysis unit can identify medication discrepancies and potentially prevent adverse drug events.

Authors:  Winnie Wy Chan; Geetha Mahalingam; Robert Ma Richardson; Olavo A Fernandes; Marisa Battistella
Journal:  J Ren Care       Date:  2015-02-19

6.  Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: a quality improvement report.

Authors:  Eric D Weinhandl; Thomas J Arneson; Wendy L St Peter
Journal:  Am J Kidney Dis       Date:  2013-04-16       Impact factor: 8.860

7.  Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider.

Authors:  Harold J Manley; Cory G Garvin; Debra K Drayer; Gerald M Reid; Walter L Bender; Timothy K Neufeld; Sudarshan Hebbar; Richard S Muther
Journal:  Nephrol Dial Transplant       Date:  2004-05-05       Impact factor: 5.992

8.  Medicare and Medicaid programs; conditions for coverage for end-stage renal disease facilities. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2008-04-15

9.  A pharmacy-based medication reconciliation and review program in hemodialysis patients: a prospective study.

Authors:  Nicholas J Patricia; Edward F Foote
Journal:  Pharm Pract (Granada)       Date:  2016-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.